Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Analyst Recommendations on JOHNSON & JOHNSON
07/19JOHNSON & JOHNSON : J&J's Janssen Seeks Europe OK For Subcutaneous Darzalex in M..
DJ
07/17J&J Lifts Forecast As Suits Weigh On Its Shares -- WSJ
DJ
07/16JOHNSON & JOHNSON : J&J warns of hit from generic drugs in third quarter, shares..
RE
07/16JOHNSON & JOHNSON : J&J warns of hit from generic drugs in third quarter, shares..
RE
07/16JOHNSON & JOHNSON : Bumps Up Sales Target--Update
DJ
07/16JOHNSON & JOHNSON : Bumps Up Sales Target
DJ
05/09Novartis buys dry eye drug from Takeda for up to $5.3 billion
RE
05/08Occidental seen as a rare victory for hedge funds tracking corporate jets
RE
04/17JOHNSON & JOHNSON : Higher Drug Sales Aid J&J Results
DJ
04/16JOHNSON & JOHNSON : Pharmaceuticals drive J&J to better-than-expected quarterly ..
RE
04/16JOHNSON & JOHNSON : Pharmaceuticals drive J&J to better-than-expected quarterly ..
RE
04/16JOHNSON & JOHNSON : Pharmaceuticals drive J&J to better-than-expected quarterly ..
RE
04/16JOHNSON & JOHNSON : Higher Prescription-Drug Sales Aid Johnson & Johnson Results..
DJ
04/16JOHNSON & JOHNSON : Correction to Johnson & Johnson Earnings Article
DJ
04/16JOHNSON & JOHNSON : Raises Full-Year Guidance
DJ
04/11JOHNSON & JOHNSON : quaterly earnings release
04/03Novartis's Alcon spinoff ousts Baer from Swiss benchmark SMI
RE
03/26JOHNSON & JOHNSON : J&J Unit Seeks FDA OK of Darzalex Combination in Multiple My..
DJ
03/22JOHNSON & JOHNSON : J&J Unit Seeks Europe OK of Darzalex Combination in Multiple..
DJ
03/05FDA Approves Controversial Drug for Depression -- Update
DJ
03/04Nightstar Therapeutics Shares Surge on Biogen Deal
DJ
02/13INTUITIVE SURGICAL : Johnson & Johnson to buy surgical robotics firm Auris for $..
RE
02/05JOHNSON & JOHNSON : Talc Claims Pose Rating, ESG Risks, Moody's Says
DJ
01/23JOHNSON & JOHNSON : J&J's Generic Rivals Pressure Its Sales
DJ
01/22JOHNSON & JOHNSON : Expects Sales Growth to Slow -- Update
DJ
01/22JOHNSON & JOHNSON : 2019 revenue forecast misses expectations
RE
01/22JOHNSON & JOHNSON : Litigation Costs Double in Fourth Quarter
DJ
01/17JOHNSON & JOHNSON : annual earnings release
2018JOHNSON & JOHNSON : J&J Hit by Baby-Powder Safety Concerns
DJ
2018JOHNSON & JOHNSON : J&J Slammed by Concern Over Baby Powder Safety
DJ
2018Johnson & Johnson shares nosedive on report it knew of asbestos in Baby Powde..
RE
2018J&J shares nosedive on report it knew of asbestos in Baby Powder
RE
2018New Parents Complain Amazon Ads Are Deceptive
DJ
2018AbbVie sees hit to Humira sales from European competition
RE
2018AbbVie sees hit to Humira sales from European competition
RE
2018Vaccines and Genzyme help Sanofi keep promise of return to growth
RE
2018JOHNSON & JOHNSON : J&J Raises Forecast as Sales Rise
DJ
2018JOHNSON & JOHNSON : Prescription Drugs Power Johnson & Johnson Results -- Update
DJ
2018JOHNSON & JOHNSON : edges past profit estimates, lifts outlook
RE
2018JOHNSON & JOHNSON : Raises Profit Outlook Following Higher Sales
DJ
2018JOHNSON & JOHNSON : Raises Profit Guidance on Rising Sales Growth
DJ
2018ConvaTec shares plunge on profit warning and CEO departure
RE
2018JOHNSON & JOHNSON : quaterly earnings release
2018J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion
RE
2018U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict
RE
2018Pfizer CEO expects Trump to eliminate drug rebates
RE
2018Pfizer CEO expects Trump to eliminate drug rebates
RE
2018JOHNSON & JOHNSON : J&J's Pharma Business Fuels Sales Growth -- WSJ
DJ
2018JOHNSON & JOHNSON : J&J beats quarterly expectations on drug sales surge, shares..
RE
2018JOHNSON & JOHNSON : Pharma Business Fuels Sales Growth -- Update
DJ
2018JOHNSON & JOHNSON : half-yearly earnings release
2018J&J Shakes Off Pricing Pressure, Plans Cost Cuts -- WSJ
DJ
2018JOHNSON & JOHNSON : J&J raises sales forecast but keeps profit outlook unchanged..
RE
2018Johnson & Johnson Raises Sales Outlook -- Update
DJ
2018JOHNSON & JOHNSON : J&J raises sales forecast on strong demand for cancer drugs
RE
2018Johnson & Johnson Raises Sales Outlook
DJ
2018JOHNSON & JOHNSON : quaterly earnings release
2018Britain's use of copycat biotech drugs takes off while U.S. lags
RE
2018JOHNSON & JOHNSON : J&J nears diabetes device exit with $2.1 bln LifeScan sale
RE
2018JOHNSON & JOHNSON : nears diabetes device exit with $2.1 billion LifeScan sale
RE
2018JOHNSON & JOHNSON : Discounts Cut J&J's Drug Prices -- WSJ
DJ
2018JOHNSON & JOHNSON : Says Discounts Cut the Prices for Its Drugs, Though Revenue ..
DJ
2018S&P 500 caps off strongest week in five years
RE
2018Drug copies ready to take next bite out of Roche's cancer sales
RE
2018Pfizer's new tax rate higher than investors hoped, shares fall
RE
2018Pfizer's new tax rate higher than investors hoped, shares fall
RE
2018Pfizer's new tax rate higher than investors hoped, shares fall
RE
2018Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
RE
2018JOHNSON & JOHNSON : J&J Posts Loss on Tax Charge; Patent Ruling Stings -- WSJ
DJ
2018Price War Pressures Consumer Brands -- WSJ
DJ
2018P&G's Price Cuts Ripple Through Consumer Products -- 2nd Update
DJ
2018JOHNSON & JOHNSON : Results Driven by Pharmaceutical Sales Growth -- 3rd Update
DJ
2018JOHNSON & JOHNSON : Results Driven by Pharmaceutical Sales Growth -- 2nd Update
DJ
2018Johnson & Johnson takes $13.6 billion charge related to new U.S. tax law
RE
2018JOHNSON & JOHNSON : Results Driven by Pharmaceutical Sales Growth -- Update
DJ
1  2  3  4  5  6  7Next
Upcoming event on JOHNSON & JOHNSON